Skip to main content
Fig. 2 | Thrombosis Journal

Fig. 2

From: Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)

Fig. 2

The percentage change in trough concentrations of edoxaban during chemotherapy with paclitaxel. A Concentrations of plasma edoxaban at each time point. Dots and error bars represent mean ± SD. B Percentage change in trough concentration of edoxaban from time points 1 to 3 (n = 15). Dots and error bars represent mean ± 95% CI. C Trough concentrations of plasma edoxaban at time points 1, 3, and 5 (n = 8). Dots and error bars represent mean ± SD. D Percentage change in trough concentrations of edoxaban from time points 1 to 5 (n = 8). Dots and error bars represent mean ± 95% CI. CI: confidence interval; inf: infinity

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us